Teva, Glenmark To Pay $305M In Latest DOJ Generics Deal
The U.S. Department of Justice announced its largest settlement to date Monday in ongoing price-fixing enforcement against major generic-drug companies, with Teva set to pay a $225 million criminal penalty and...To view the full article, register now.
Already a subscriber? Click here to view full article